Stocks
ORIC Pharmaceuticals, Inc.ORIC
NASDAQHealthcareBiotechnology$12.72
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing oral therapies for patients with difficult-to-treat cancers, including prostate and breast cancer. Its lead candidates target resistance mechanisms in hormone-driven tumors, and the company is advancing multiple programs through early-stage clinical trials. Investors track ORIC for its focus on overcoming treatment resistance, a key challenge in oncology.
52W Range: $7.23-$14.68
Congressional Interest in ORIC Pharmaceuticals, Inc. (ORIC)
No congressional trades have been disclosed for ORIC Pharmaceuticals, Inc. (ORIC) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ORIC?
No congressional trades found for this stock.